End-of-Life Care in the Treatment of Heart Failure in the Elderly

Clinics in Geriatric Medicine

Volumn 23, Issue 1, 2007, Pages 235-248

  McClung, John Arthur ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HALOPERIDOL; INOTROPIC AGENT; LORAZEPAM; MIDAZOLAM; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OLANZAPINE; OPIATE; PROPOFOL; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VASODILATOR AGENT;

ANEMIA; ARTHROPATHY; CARDIAC RESYNCHRONIZATION THERAPY; CAREGIVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DATA BASE; DECISION MAKING; DEFIBRILLATOR; DIABETES MELLITUS; DRUG ANTAGONISM; DYSPNEA; ECHOCARDIOGRAPHY; EDEMA; FATIGUE; GERIATRIC CARE; HALLUCINATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEART EJECTION FRACTION; HEART FAILURE; HEART PACING; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; MEDICAL ETHICS; MEDICAL LITERATURE; OXYGEN SATURATION; PAIN; PALLIATIVE THERAPY; PLEURA EFFUSION; POSITIVE END EXPIRATORY PRESSURE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RESUSCITATION; REVIEW; SOCIAL LIFE; SOCIAL SUPPORT; SODIUM RETENTION; THORACOCENTESIS; UNSPECIFIED SIDE EFFECT;

AGED; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HUMANS; PALLIATIVE CARE; TERMINAL CARE; TERMINALLY ILL;

EID: 33751173645     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2006.08.009     Document Type: Review

References (67)

1. AGS Ethics Committee. American Geriatrics Society Position Statement: The care of dying patients. J Am Geriatr Soc 43 (1995) 577-578
2. Lamont E.B., and Christakis N.A. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134 (2001) 1096-1105
3. Lamont E.B., and Christakis N.A. Complexities in prognostication in advanced cancer. JAMA 290 (2003) 98-104
4. Cowburn P.J., Cleland J.G.F., Coats A.J.S., et al. Risk stratification in chronic heart failure. Eur Heart J 19 (1998) 696-710
5. Lee W.H., and Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 73 (1986) 257-267
6. Cohn J.N., Johnson G., Ziesche S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 (1991) 303-310
7. Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure. Circulation 105 (2002) 2328-2331
8. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
9. Watanabe J., Shinozaki T., Shiba N., et al. Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. Eur J Heart Fail 8 (2006) 237-242
10. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
11. Daubert J.P., Zareba W., Hall W.J., et al. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in multicenter automatic defibrillator implantation trial (MADIT) II patients. J Am Coll Cardiol 47 (2006) 98-107
12. Bouvy M.L., Heerdink E.R., Leufkens H.G.M., et al. Predicting mortality in patients with heart failure: a pragmatic approach. Heart 89 (2003) 605-609
13. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
14. Weeks J.C., Cook E.F., O'Day S.J., et al. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279 (1998) 1709-1714
15. Murray S.A., Boyd K., Kendall M., et al. Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. BMJ 325 (2002) 929-933
16. Faber-Langendoen K. A multi-institutional study of care given to patients dying in hospitals: ethical and practice implications. Arc Intern Med 156 (1996) 2130-2136
17. Goldstein N.E., and Lynn J. Trajectory of end-stage heart failure: the influence of technology and implications for policy change. Perspect Biol Med 49 1 (2006) 10-19
18. McCarthy M., Lay M., and Addington-Hall J. Dying from heart disease. J R Coll Phys London 30 (1996) 325-328
19. Covinsky K., Goldman L., Cook E., et al. The impact of serious illness on patients' families. JAMA 272 (1994) 1839-1844
20. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 274 (1995) 1591-1598
21. Lynn J., Teno J.M., Phillips R.S., et al. Perceptions of family members of the dying experience of older and seriously ill patients. Ann Intern Med 126 (1997) 97-106
22. Emanuel E.J., Fairclough D.L., Wolfe P., et al. Talking with terminally ill patients and their caregivers about death, dying, and bereavement: Is it stressful? Is it helpful?. Arch Intern Med 164 (2004) 1999-2004
23. Stewart S., and McMurray J.J.V. Palliative care for heart failure: time to move beyond treating and curing to improving the end of life. BMJ 325 (2002) 915-916
24. Murray S.A., Boyd K., and Sheikh A. Palliative care in chronic illness: we need to move from prognostic paralysis to active total care. BMJ 330 (2005) 611-612
25. Hauptman P.J., and Havranek E.P. Integrating palliative care into heart failure care. Arch Intern Med 165 (2005) 374-378
26. Williams S.G., Wright D.J., Marshall P., et al. Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 89 (2003) 1085-1086
27. Levenson J.W., McCarthy E.P., Lynn J., et al. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 48 5 Suppl (2000) S101-S109
28. Bleumink G.S., Feenstra J., Sturkenboom M.C., et al. Nonsteroidal anti-inflammatory drugs and heart failure. Drugs 63 (2003) 525-534
29. Bradley T.D., Logan A.G., Kimoff J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 (2005) 2025-2033
30. VanVeldhuisen D.J., Dickstein K., Cohen-Solal A., et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa on hemoglobin response and symptoms in patients with heart failure and anemia. J Am Coll Cardiol 47 Suppl A (2006) 61A
31. Ward C. The need for palliative care in the management of heart failure. Heart 87 (2002) 294-298
32. Beck A., Scott J., Williams P., et al. A randomized trial of group outpatient visits for chronically ill older HMO members: The cooperative health care clinic. J Am Geriatr Soc 45 (1997) 543-549
33. Heart Failure Society of America. Advance care planning (Module 9) (2005), Heart Failure Society of America, St. Paul
34. Heart Failure Society of America. Managing feelings about heart failure (Module 6) (2005), Heart Failure Society of America, St. Paul
35. Albert N.M., Davis M., and Young J. Improving the care of patients dying of heart failure. Cleve Clin J Med 69 (2002) 321-328
36. Murray S.A., Kendall M., Boyd K., et al. Exploring the spiritual needs of people dying of lung cancer or heart failure: a prospective qualitative interview study of patients and their carers. Palliat Med 18 (2004) 39-45
37. Bailey F.A., Burgio K.L., Woodby L.L., et al. Improving processes of hospital care during the last hours of life. Arch Intern Med 165 (2005) 1722-1727
38. Gibbs J.S.R., McCoy A.S.M., Gibbs L.M.E., et al. Living with and dying from heart failure: the role of palliative care. Heart 88 Suppl II (2002) II36-II39
39. Gostin L.O. Deciding life and death in the courtroom: from Quinlan to Cruzan, Glucksberg, and Vacco-a brief history and analysis of constitutional protection of the "right to die.". JAMA 278 (1997) 1523-1528
40. Snyder L., and Leffler C. Ethics manual: fifth edition. Ann Intern Med 142 (2005) 560-582
41. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. Circulation 112 (2005) 1825-1852
42. Gillick M.R. Advance care planning. N Engl J Med 350 (2004) 7-8
43. Greco P.J., Schulman K.A., Lavizzo-Mourey R., et al. The Patient Self-Determination Act and the future of advance directives. Ann Intern Med 115 (1991) 639-643
44. Goldstein N.E., Lampert R., Bradley E., et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 141 (2004) 835-838
45. Berger J.T. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 142 (2005) 631-634
46. Braun T.C., Hagen N.A., Hatfield R.E., et al. Cardiac pacemakers and implantable defibrillators in terminal care. J Pain Symptom Manage 18 (1999) 126-131
47. Cleland J., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
48. Carson P., Anand I., O'Connor C., et al. Mode of death in advanced heart failure: the comparison of medical, pacing, and defibrillation therapies in heart failure (COMPANION) trial. J Am Coll Cardiol 46 (2005) 2329-2334
49. Bax J.J., Abraham T., Barold S., et al. Cardiac resynchronization therapy: Part 2-Issues during and after device implantation and unresolved questions. J Am Coll Cardiol 46 (2005) 2168-2182
50. Mueller P.S., Hook C.C., and Hayes D.L. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc 78 (2003) 959-963
51. Stevenson L.W. Rites and responsibility for resuscitation in heart failure: Tread gently on the thin places. Circulation 98 (1998) 619-622
52. Krumholz H.M., Phillips R.S., Hamel M.B., et al. Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Circulation 98 (1998) 648-655
53. Tsai E. Should family members be present during cardiopulmonary resuscitation?. N Engl J Med 346 (2002) 1019-1021
54. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care-Part 2: Ethical issues. Circulation 112 Suppl IV (2005) IV6-IV11
55. Casarett D., and Inouye S. Diagnosis and management of delirium near the end of life. Ann Intern Med 135 (2001) 32-40
56. Lo B., and Rubenfeld G. Palliative sedation in dying patients: "We turn to it when everything else hasn't worked.". JAMA 294 (2005) 1810-1816
57. Quill T.E., Dresser R., and Brock D.W. The rule of double effect - a critique of its role in end-of-life decision making. N Engl J Med 337 (1997) 1768-1771
58. Wilson W.C., Smedira N.G., Fink C., et al. Ordering and administration of sedatives and analgesics during the withholding and withdrawal of life support from critically ill patients. JAMA 267 (1992) 949-953
59. Sulmasy D.P., and Pellegrino E.D. The rule of double effect: clearing up the double talk. Arch Intern Med 159 (1999) 545-550
60. Sulmasy D.P. Double effect: Intention is the solution, not the problem. J Law Med Ethics 28 1 (2000) 26-29
61. Brody H. Causing, intending, and assisting death. J Clin Ethics 4 (1993) 112-118
62. Jansen L.A., and Sulmasy D.P. Sedation, alimentation, hydration, and equivocation: Careful conversation about care at the end of life. Ann Intern Med 136 (2002) 845-849
63. Barnard D. The skull at the banquet. In: Jansen L. (Ed). Death in the clinic (2006), Rowman & Littlefield, Lanham, MD 66-80
64. Kearney M. Mortally wounded: stories of soul pain, death, and healing (1996), Scribner, New York 131
65. Steinhauser K.E., Clipp E.C., McNeilly M., et al. In search of a good death: observations of patients, families, and providers. Ann Intern Med 132 (2000) 825-832
66. McCue J.D. The naturalness of dying. JAMA 273 (1995) 1039-1042
67. Goodlin S.J., Hauptman P.J., Arnold R., et al. Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail 10 (2004) 200-209